Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
In 2022, AACR launched a unique initiative called AACR Maximizing Opportunity for New Advancements in Research in Cancer (MONARCA)...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of...
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...